Cassava Sciences, Inc.
SAVA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $141 | $87 | $72 | $114 |
| - Cash | $0 | $112 | $117 | $129 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $141 | -$25 | -$45 | -$15 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$5 | -$14 | -$21 |
| % Margin | – | – | – | – |
| EBITDA | -$11 | -$14 | -$21 | -$19 |
| % Margin | – | – | – | – |
| Net Income | -$11 | -$44 | -$23 | -$28 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.22 | -0.92 | -0.48 | -0.57 |
| % Growth | 76.1% | -91.7% | 15.8% | – |
| Operating Cash Flow | -$6 | -$5 | -$11 | -$61 |
| Capital Expenditures | -$0 | $0 | $0 | -$0 |
| Free Cash Flow | -$6 | -$5 | -$11 | -$61 |